M&A activity related to virtual care increased in the pharmaceutical Leave a comment
Source
<!–
–>
In value terms, virtual care-related deal activity increased by 7003% in Q1 2023 compared with the previous quarter’s total of $6m. Related deal volume increased by 100% in Q1 2023 versus the previous quarter and was 500% higher than in Q1 2022.
<![CDATA[!function(){"use strict";window.addEventListener("message",(function(a){if(void 0!==a.data["datawrapper-height"]){var e=document.querySelectorAll("iframe");for(var t in a.data["datawrapper-height"])for(var r=0;r<![CDATA[!function(){"use strict";window.addEventListener("message",(function(a){if(void 0!==a.data["datawrapper-height"]){var e=document.querySelectorAll("iframe");for(var t in a.data["datawrapper-height"])for(var r=0;r
The top-ranked legal advisors supporting these M&A deals in Q1 2023 were Greenberg Traurig; Morrison Foerster; Sheppard, Mullin, Richter & Hampton with 1, 1, 1 deals respectively.
For further understanding of GlobalData’s Telehealth Market Size by Segments, Share, Trends, and Forecast, 2022-2030 buy the report here.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.
